America Stem Cell, Inc. (Floresville, TX) Awarded a Phase I STTR to Explore the Therapeutic Potential of Its Platform Technology (ASC-101) With Amniotic Fluid-Derived Stem Cells
9/17/2012 9:56:10 AM
More...
|
America Stem Cell, Inc. (Helotes, TX) Initiates a Phase I/II Trial of ASC-101 in Patients With Hematologic Malignancies Undergoing Dual-Cord Transplantation
8/28/2012 9:54:51 AM
More...
|